{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:04Z","timestamp":1786991104352,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113439","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T03:51:14Z","timestamp":1729569074000},"page":"113439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Anti-Inflammatory effect of INSL-3 on experimental arthritis model and LPS-induced macrophage cell line"],"prefix":"10.1016","volume":"143","author":[{"given":"Gulfidan","family":"Coskun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Saker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samat","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugce","family":"Sapmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Celenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leman","family":"Sencar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagil","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sait","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113439_b0005","series-title":"Understanding rheumatoid arthritis","author":"Fitzpatrick","year":"2005"},{"issue":"11","key":"10.1016\/j.intimp.2024.113439_b0010","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.amjmed.2007.04.005","article-title":"Rheumatoid arthritis: diagnosis and management","volume":"120","author":"Majithia","year":"2007","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.113439_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/1529-0131(200108)45:4<317::AID-ART343>3.0.CO;2-X","article-title":"Development of an instrument to measure pain in rheumatoid arthritis: Rheumatoid Arthritis Pain Scale (RAPS)","volume":"45","author":"Anderson","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.intimp.2024.113439_b0020","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/art.21450","article-title":"Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored","volume":"53","author":"Hewlett","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.intimp.2024.113439_b0025","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"6937","key":"10.1016\/j.intimp.2024.113439_b0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.intimp.2024.113439_b0035","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.3390\/ijms20235867","article-title":"Osteoporosis in Rheumatic Diseases","volume":"20","author":"Adami","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113439_b0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.rdc.2006.07.002","article-title":"Epidemiology of osteoporosis in rheumatic diseases","volume":"32","author":"Sinigaglia","year":"2006","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"7","key":"10.1016\/j.intimp.2024.113439_b0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","article-title":"Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE","volume":"7","author":"Symmons","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113439_b0050","first-page":"286","article-title":"Extra-articular Manifestations in Rheumatoid Arthritis","volume":"5","author":"Cojocaru","year":"2010","journal-title":"Maedica (Bucur)."},{"issue":"10","key":"10.1016\/j.intimp.2024.113439_b0055","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk","volume":"32","author":"Mellemkjaer","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2024.113439_b0060","article-title":"Physiotherapy in rheumatoid arthritis","volume":"6","author":"Kavuncu","year":"2004","journal-title":"MedGenMed"},{"issue":"7","key":"10.1016\/j.intimp.2024.113439_b0065","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0091270005277938","article-title":"Rheumatoid arthritis: an overview of new and emerging therapies","volume":"45","author":"Doan","year":"2005","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113439_b0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.reuma.2011.01.008","article-title":"Glucocorticoides en artritis reumatoide: \u00bfcasi siempre o casi nunca? [Glucocorticoids in rheumatoid arthritis: almost always or hardly ever?]","volume":"7","author":"Blanco-Morales","year":"2011","journal-title":"Reumatol Clin."},{"issue":"1","key":"10.1016\/j.intimp.2024.113439_b0075","doi-asserted-by":"crossref","first-page":"e000536","DOI":"10.1136\/rmdopen-2017-000536","article-title":"Glucocorticoids in rheumatoid arthritis: current status and future studies","volume":"6","author":"Hua","year":"2020","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.intimp.2024.113439_b0080","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2024.113439_b0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data","volume":"65","author":"Silva","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"5 Suppl 35","key":"10.1016\/j.intimp.2024.113439_b0090","first-page":"S77","article-title":"Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks","volume":"22","author":"Townsend","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113439_b0095","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/jbmr.3523","article-title":"Glucocorticoid Exposure and Fracture Risk in a Cohort of US Patients With Selected Conditions","volume":"33","author":"Balasubramanian","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.intimp.2024.113439_b0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bone.2018.06.008","article-title":"The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials","volume":"114","author":"Blavnsfeldt","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2024.113439_b0105","article-title":"Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons","volume":"7","author":"Llorente","year":"2020","journal-title":"Front Med (Lausanne)."},{"issue":"2","key":"10.1016\/j.intimp.2024.113439_b0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cyto.2014.04.006","article-title":"Poly(ADP-ribose), polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model","volume":"68","author":"Ahmad","year":"2014","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.intimp.2024.113439_b0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/intimm\/dxt075","article-title":"Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis","volume":"26","author":"Abd-Allah","year":"2014","journal-title":"Int Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113439_b0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/humupd\/dmp011","article-title":"Biology of insulin-like factor 3 in human reproduction","volume":"15","author":"Ivell","year":"2009","journal-title":"Hum. Reprod. Update"},{"issue":"6","key":"10.1016\/j.intimp.2024.113439_b0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1095\/biolreprod.113.108969","article-title":"INSL3 as a biomarker of Leydig cell functionality","volume":"88","author":"Ivell","year":"2013","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.intimp.2024.113439_b0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1749-6632.2008.03787.x","article-title":"New roles for INSL3 in adults","volume":"1160","author":"Ferlin","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113439_b0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tem.2006.03.004","article-title":"Neohormone systems as exciting targets for drug development","volume":"17","author":"Ivell","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.intimp.2024.113439_b0140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1196\/annals.1282.074","article-title":"Insulin-like factor 3: a novel circulating hormone of testicular origin in humans","volume":"1041","author":"Ferlin","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2024.113439_b0145","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bph.13529","article-title":"Anti-fibrotic actions of relaxin","volume":"174","author":"Samuel","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113439_b0150","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1095\/biolreprod.110.089201","article-title":"Relaxin modulates proinflammatory cytokine secretion from human decidual macrophages","volume":"85","author":"Horton","year":"2011","journal-title":"Biol. Reprod."},{"issue":"759","key":"10.1016\/j.intimp.2024.113439_b0155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejphar.2015.03.047","article-title":"Animal models of rheumatoid arthritis: How informative are they?","volume":"15","author":"McNamee","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113439_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/cs1040027","article-title":"The inflammatory macrophage: a story of Jekyll and Hyde","volume":"104","author":"Duffield","year":"2003","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.intimp.2024.113439_b0165","article-title":"Ellagic acid attenuates testicular disruption in rheumatoid arthritis via targeting inflammatory signals, oxidative perturbations and apoptosis","volume":"239","author":"Arab","year":"2009","journal-title":"Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2024.113439_b0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2013.09.019","article-title":"Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis","volume":"718","author":"Suke","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113439_b0175","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.107.122903","article-title":"Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis","volume":"322","author":"Santora","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2024.113439_b0180","doi-asserted-by":"crossref","first-page":"e79284","DOI":"10.1371\/journal.pone.0079284","article-title":"Targeting TNF-\u03b1 and NF-\u03baB activation by bee venom: role in suppressing adjuvant induced arthritis and methotrexate hepatotoxicity in rats","volume":"8","author":"Darwish","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.113439_b0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.intimp.2016.01.006","article-title":"Combined treatment with low dose prednisone and escin improves the anti-arthritic effect in experimental arthritis","volume":"31","author":"Du","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2024.113439_b0190","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fimmu.2020.00730","article-title":"Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis","volume":"5","author":"Na","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113439_b0195","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/1087057107299261","article-title":"Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs","volume":"12","author":"H\u00e4upl","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.intimp.2024.113439_b0200","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fimmu.2018.00036","volume":"9","author":"Eren","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113439_b0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3109\/09553002.2015.1031408","article-title":"Modulation of cytokine levels in ameliorative effects of pulsed magnetic field on an experimental model of Chronic Constriction Injury","volume":"91","author":"Mert","year":"2015","journal-title":"Int. J. Radiat Biol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113439_b0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/bem.22343","article-title":"A Low-Frequency Pulsed Magnetic Field Reduces Neuropathic Pain by Regulating NaV1.8 and NaV1.9 Sodium Channels at the Transcriptional Level in Diabetic Rats","volume":"42","author":"Coskun","year":"2021","journal-title":"Bioelectromagnetics"},{"issue":"1","key":"10.1016\/j.intimp.2024.113439_b0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuron.2006.09.021","article-title":"Mechanisms of neuropathic pain","volume":"52","author":"Campbell","year":"2006","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.intimp.2024.113439_b0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/bem.20524","article-title":"Neurobiological effects of pulsed magnetic field on diabetes-induced neuropathy","volume":"31","author":"Mert","year":"2010","journal-title":"Bioelectromagnetics"},{"key":"10.1016\/j.intimp.2024.113439_b0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.imlet.2020.06.014","article-title":"CXC chemokine receptor 3 antagonist AMG487 shows potent anti-arthritic effects on collagen-induced arthritis by modifying B cell inflammatory profile","volume":"225","author":"Bakheet","year":"2020","journal-title":"Immunol Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.113439_b0230","first-page":"377","article-title":"Animal models of rheumatoid arthritis","volume":"1","author":"Bendele","year":"2001","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"4","key":"10.1016\/j.intimp.2024.113439_b0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.vph.2005.02.001","article-title":"Evaluation of antioxidant effect of Semecarpus anacardium Linn. nut extract on the components of immune system in adjuvant arthritis","volume":"42","author":"Ramprasath","year":"2005","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113439_b0240","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.2147\/JPR.S325988","article-title":"Styphnolobium japonicum (L.) Schott Flower Extract Alleviates Oxidative Stress and Inflammatory Factors in the Adjuvant-Induced Arthritis Rat Model","volume":"14","author":"Liu","year":"2021","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.113439_b0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/019262339702500103","article-title":"Clinical and histological assessment of collagen-induced arthritis progression in the diabetes-resistant BB\/Wor rat","volume":"25","author":"Knoerzer","year":"1997","journal-title":"Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113439_b0250","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00393-012-1083-8","article-title":"Evaluation of complete Freund's adjuvant-induced arthritis in a Wistar rat model","volume":"72","author":"Snekhalatha","year":"2013","journal-title":"Z Rheumatol."},{"key":"10.1016\/j.intimp.2024.113439_b0255","doi-asserted-by":"crossref","first-page":"1658618","DOI":"10.1155\/2020\/1658618","article-title":"N-Butanol Extract of Gastrodia elata Suppresses Inflammatory Responses in Lipopolysaccharide-Stimulated Macrophages and Complete Freund's Adjuvant- (CFA-) Induced Arthritis Rats via Inhibition of MAPK Signaling Pathway","volume":"2020","author":"He","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.113439_b0260","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pathophys.2005.07.005","article-title":"Synovial biology and T cells in rheumatoid arthritis","volume":"12","author":"Tran","year":"2005","journal-title":"Pathophysiology"},{"key":"10.1016\/j.intimp.2024.113439_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790925","article-title":"Antcin K Inhibits TNF-\u03b1, IL-1\u03b2 and IL-8 Expression in Synovial Fibroblasts and Ameliorates Cartilage Degradation: Implications for the Treatment of Rheumatoid Arthritis","volume":"12","author":"Achudhan","year":"2021","journal-title":"Front. Immunol."},{"issue":"10086","key":"10.1016\/j.intimp.2024.113439_b0270","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2024.113439_b0275","first-page":"158","article-title":"Sociedade Brasileira de Reumatologia. Guidelines for the drug treatment of rheumatoid arthritis","volume":"53","author":"Mota","year":"2013","journal-title":"Rev. Bras. Reumatol."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2024.113439_b0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2011.11.052","article-title":"Effect of atorvastatin with or without prednisolone on Freund's adjuvant induced-arthritis in rats","volume":"676","author":"Abdin","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113439_b0285","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/03008208109152129","article-title":"Effect of adjuvant induced arthritis on the mechanical properties and thermal behavior of skin and tendon","volume":"8","author":"Kuberasampath","year":"1981","journal-title":"Connect. Tissue Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.113439_b0290","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/ar3038","article-title":"Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis","volume":"12","author":"Peterson","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2024.113439_b0295","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1254\/jjp.90.236","article-title":"Effects of methylprednisolone on bone formation and resorption in rats","volume":"90","author":"Wang","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2024.113439_b0300","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.regpep.2012.07.003","article-title":"Insulin-like peptide 3 stimulates testosterone secretion in mouse Leydig cells via cAMP pathway","volume":"178","author":"Pathirana","year":"2012","journal-title":"Regul. Pept."},{"issue":"10","key":"10.1016\/j.intimp.2024.113439_b0305","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/bph.13656","article-title":"Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1","volume":"174","author":"Agoulnik","year":"2017","journal-title":"Br. J. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924019611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924019611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T21:33:15Z","timestamp":1736285595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924019611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":61,"alternative-id":["S1567576924019611"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113439","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Inflammatory effect of INSL-3 on experimental arthritis model and LPS-induced macrophage cell line","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113439"}}